Company Revenue

The company declined in the mid-single digits during the third quarter of 2024 as it pivots away from Arthrosurface and...

The company grew more than 27% in the third quarter of 2024 as it hones its focus on attaining cash...

The company grew in the mid-single digits in the third quarter of 2024 as it worked through ERP-related issues impacting...

The company's orthopedic sales grew nearly 5% in the third quarter of 2024 but hurricane impacts will impact fourth quarter...

The company's orthopedic sales grew in the double digits during the third quarter of 2024 amid robust volume and demand....

The company grew over 50% in the third quarter of 2024, driven by continued U.S. market penetration and hospital approvals....

The company's orthopedic sales grew in the low single digits in the third quarter of 2024 on restructuring and APAC...

The company drove mid-single-digit sales growth in the first quarter of its 2025 fiscal year driven by pull through from...

The company grew in the mid-single digits during the second quarter of 2024 as it looks to expand its presence...

The company grew 20% in the second quarter of 2024 driven by an expanding portfolio and active surgeon base....